99mTc-sestaMIBI scintigraphy in thalidomide-treated refractory or relapsed multiple myeloma patients

Breast cancer risk in female survivors of Hodgkin lymphoma after exposure to non-pegylated liposomal doxorubicin at young adult and adult age: the first real-life series from Southern Italy cancer centers.

Annals of hematology·2026

Brentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine for Patients Aged 18-59 Years With Untreated Advanced Stage Classical Hodgkin Lymphoma: The Largest Real-Life Series From Southern Italy Cancer Centers.

European journal of haematology·2025

Texture Analysis of 68Ga-DOTATOC PET/CT Images for the Prediction of Outcome in Patients with Neuroendocrine Tumors.

Biomedicines·2025

Prognostic Value of Tumor Dissemination (Dmax) Derived from Basal 18F-FDG Positron Emission Tomography/Computed Tomography in Patients with Advanced Non-Small-Cell Lung Cancer.

Biomedicines·2025

External validation of a predictive model for post-treatment persistent disease by 131I whole-body scintigraphy in patients with differentiated thyroid cancer.

European journal of nuclear medicine and molecular imaging·2025

Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myeloma.

Annals of hematology·2024

Prognostic factors of 10-year survival in patients with myeloma after autologous stem cell transplantation: a multicenter retrospective analysis.

Leukemia & lymphoma·2026

Evaluation of hypomethylating agents with or without venetoclax in patients with accelerated phase and blast phase myeloproliferative neoplasms: a HERO consortium study.

Leukemia & lymphoma·2026

Soluble PD-L1 as prognostic biomarker in acute myeloid leukemia.

Leukemia & lymphoma·2026

Dose optimization of single-agent inotuzumab ozogamicin in adults with relapsed/refractory acute lymphoblastic leukemia.

Leukemia & lymphoma·2026

Impact of Area Deprivation Index in patients with newly diagnosed acute myeloid leukemia treated with a venetoclax-based regimen: a single-center retrospective study.

Leukemia & lymphoma·2026

Palliative care and hospice utilization in patients with relapsed or refractory diffuse large B-cell lymphoma in the era of CART and novel immunotherapies.

Leukemia & lymphoma·2026

Lipid Metabolism in Regulatory T Cells in Health and Disease.

Journal of inflammation research·2026

The diagnosis and management of primary mediastinal B-cell lymphoma: A British Society for Haematology guideline.

British journal of haematology·2026

Anakinra Prophylaxis for Recurrent Severe ICANS Associated With Tarlatamab in Small Cell Lung Cancer: Case Report.

JTO clinical and research reports·2026

Prognostic value of CD103+ tumor-infiltrating lymphocytes in bladder cancer: A systematic review and meta-analysis.

Urologic oncology·2026

Immunotherapy for Glioma: A compartmental framework for resistance and rational combination design.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026

B-cells in breast cancer: current insights and challenges.

Frontiers in oncology·2026

Related Experiment Videos

99mTc-sestaMIBI scintigraphy in thalidomide-treated refractory or relapsed multiple myeloma patients

Related Concept Videos

Breast cancer risk in female survivors of Hodgkin lymphoma after exposure to non-pegylated liposomal doxorubicin at young adult and adult age: the first real-life series from Southern Italy cancer centers.

Brentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine for Patients Aged 18-59 Years With Untreated Advanced Stage Classical Hodgkin Lymphoma: The Largest Real-Life Series From Southern Italy Cancer Centers.

Texture Analysis of 68Ga-DOTATOC PET/CT Images for the Prediction of Outcome in Patients with Neuroendocrine Tumors.

Prognostic Value of Tumor Dissemination (Dmax) Derived from Basal 18F-FDG Positron Emission Tomography/Computed Tomography in Patients with Advanced Non-Small-Cell Lung Cancer.

External validation of a predictive model for post-treatment persistent disease by 131I whole-body scintigraphy in patients with differentiated thyroid cancer.

Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myeloma.

Prognostic factors of 10-year survival in patients with myeloma after autologous stem cell transplantation: a multicenter retrospective analysis.

Evaluation of hypomethylating agents with or without venetoclax in patients with accelerated phase and blast phase myeloproliferative neoplasms: a HERO consortium study.

Soluble PD-L1 as prognostic biomarker in acute myeloid leukemia.

Dose optimization of single-agent inotuzumab ozogamicin in adults with relapsed/refractory acute lymphoblastic leukemia.

Impact of Area Deprivation Index in patients with newly diagnosed acute myeloid leukemia treated with a venetoclax-based regimen: a single-center retrospective study.

Palliative care and hospice utilization in patients with relapsed or refractory diffuse large B-cell lymphoma in the era of CART and novel immunotherapies.

Lipid Metabolism in Regulatory T Cells in Health and Disease.

The diagnosis and management of primary mediastinal B-cell lymphoma: A British Society for Haematology guideline.

Anakinra Prophylaxis for Recurrent Severe ICANS Associated With Tarlatamab in Small Cell Lung Cancer: Case Report.

Prognostic value of CD103+ tumor-infiltrating lymphocytes in bladder cancer: A systematic review and meta-analysis.

Immunotherapy for Glioma: A compartmental framework for resistance and rational combination design.

B-cells in breast cancer: current insights and challenges.

Related Experiment Videos

99mTc-sestaMIBI scintigraphy in thalidomide-treated refractory or relapsed multiple myeloma patients

Related Concept Videos

Related Articles